首页> 外文期刊>International urogynecology journal and pelvic floor dysfunction >A repeat mid-urethral sling as valuable treatment for persistent or recurrent stress urinary incontinence
【24h】

A repeat mid-urethral sling as valuable treatment for persistent or recurrent stress urinary incontinence

机译:重复中尿道吊索,作为持续或复发性压力尿失禁的有价值的治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction and hypothesis: The value of a repeat mid-urethral sling (MUS) after a failed primary sling is not generally accepted. We hypothesize that repeat MUS can be performed with favorable results and acceptable complication rates. Methods: We reviewed the medical records of 80 women (mean age 62 ± 12.3 years) who underwent repeat MUS surgery from January 2000 to January 2009 at a single tertiary academic centre. Mean follow-up was 44.8 months (range 3-104). Three of these 80 patients were lost to follow-up. Twenty-six (33%) transobturator (TOT), 25 (31%) retropubic (TVT) and 16 (20%) minislings were placed as secondary slings. Thirteen slings (15%) were biological (Pelvicol?). In 4 patients (5%) a release of the primary sling was performed, and in 6 (7.5 %) the extruded sling fragment was totally excised prior to secondary sling placement. Results: The overall subjective cure rate was 61.0%. Of the study group 74.0% reported subjective improvement. The amounts of pads reduced from a mean of 3.8 pads a day to a mean of 0.75 pads a day postoperatively. The objective cure rate was 63.5%. The incidence of de novo urgency was 8.2% (4 patients). When comparing different secondary sling types no difference was found in the overall continence rate, except for the biological sling. More than half (7 out of 13) of the patients from whom the secondary sling was a biological sling, were not satisfied (p = 0.01). The subjective improvement rates in patients with recurrent or persistent stress urinary incontinence (SUI) were 68.2% and 75.0% respectively. This difference is not statistically significant (p = 0.94). Excision versus release of the MUS showed a slightly higher satisfaction rate after excision, 84.6% and 74.0 % respectively (p = 0.63). Conclusions: Cure rates and improvement rates of a repeat MUS are favorable and complication rates are acceptable. It should be offered to patients with persistent or recurrent SUI after a failed primary sling, even after previous release or excision.
机译:引言和假设:通常不接受失败的主吊索后重复中尿道吊索(MU)的值。我们假设可以用有利的结果和可接受的并发症率进行重复肌肉。方法:我们审查了80名女性的病历(平均年龄62±12.3岁),他于2000年1月至2009年1月在一个三级学术中心接受了重复的MUS手术。平均随访时间为44.8个月(范围3-104)。这80名患者中的三个失去了随访。将二十六(33%)转基因仪(TOT),25(31%)宿潮(TVT)和16(20%)缩小作为次要吊索。十三个吊索(15%)是生物学(骨盆?)。在4名患者中(5%)进行初级吊带的释放,在6(7.5%)中,在二次吊带放置之前完全切除挤出的吊带片段。结果:整体主观治愈率为61.0%。研究组74.0%报告了主观改善。垫子每天从3.8垫的平均值减少3.8垫的平均值,术后每天0.75垫。客观固化率为63.5%。 De Novo诉状的发病率为8.2%(4名患者)。除了生物吊索之外,在比较不同的二级吊带类型的情况下没有发现整体欧元率。不满足二次吊带是生物吊索的患者的一半以上(13分)(P = 0.01)。复发性或持续压力尿失禁患者(SUI)的主观改善率分别为68.2%和75.0%。这种差异在统计学上没有统计学意义(p = 0.94)。切除释放的切除释放在切除后的满意度略高,分别为84.6%和74.0%(P = 0.63)。结论:治愈率和重复炎症的改善率是有利的,并发症率是可接受的。在前一次释放或切除之后,在失败的原发性吊带后,应该向患有持续或复发性的隋尿的患者提供。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号